David Einhorn acquired 2.14 Million Chemours Company shares worth $73.7 Million. That's 6.13% of their entire equity portfolio (6th largest holding). The investor owns 1.36% of the outstanding Chemours Company stock. The first Chemours Company trade was made in Q4 2015. Since then David Einhorn bought shares eight more times and sold shares on fifteen occasions. The stake costed the investor $51.5 Million, netting the investor a gain of 43% so far.